Description
Combating acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer
Article: Combating acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer
€2.42
€2.42
Combating acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer
Top